Ann: Botanix Presents at Fall Clinical Dermatology Conference, page-121

Some energy could be coming sideways after the mid term elections in the US.
If the ex speaker of the house - John Boehner - is right, legalization is a done deal with Trump already in favour of it.
Legalization would see large funds scanning the sector for opportunities with their capital inflow reverberating across all applications. In fact it's reasonable to see that big money is impatient to seize on the industry, but to do so it needs to be brought into the federal fold and be legalized.

Check the video below with Boehner, ......there's a clue (with the logos of some big pharma like J&J, Novartis) that..."big investment firms and members of Fortune500 are building enormous war chests"....

https://pro.nicinvestors.com/p/CIRLNC39V/PCIRUB07/?h=true

....and more remarks from Boehner:

https://www.prnewswire.com/news-rel...to-pour-into-cannabis-industry-300739572.html

The effects of legalization would be felt across and beyond and BOT would most certainly come to the fore of attentions with its first and only FDA supported trial for cannabidiol applications in dermatology.
Timing is paramount in investing and BOT could benefit from a timely Trump' second term policy that opens the doors to .."enormous war chests".